Mr. Alexander describes the importance of blood-conservation strategies, including the use of drugs, that can be beneficial during procedures such as transfusions and coronary artery bypass grafting.
You are here
P&T® Journal contents for December 2005
American Society of Hematology State-of-the-Art Symposium: Myeloma and Lymphoma: Recent Advances in Biology and Therapy
Progress is being made in the way tumors are being targeted by agents such as lenalidomide, bortezomib, rituximab, and a variety of other novel chemotherapeutic regimens.
The Prescotts discuss hormonal replacement therapy; lasofoxifene for vaginal atrophy; testosterone for low libido; alendronate, transdermal estrogen, risedronate, and ibandronate for osteoporosis; and the transdermal oxybutynin patch for overactive bladder.
Continuing Education Credit
When switching patients from one selective serotonin reuptake inhibitor to another, health care providers need to consider several factors, namely, the pharmacokinetic profile of the current drug, the possibility of serotonin syndrome, and withdrawal symptoms.